Cargando…

CXXC5 Attenuates Pulmonary Fibrosis in a Bleomycin-Induced Mouse Model and MLFs by Suppression of the CD40/CD40L Pathway

OBJECTIVE: To investigate the role of CXXC5 and the CD40/CD40L pathway in lung fibrosis. METHODS: (1) We constructed mouse models of bleomycin-induced pulmonary fibrosis and transfected them with a CXXC5 overexpression vector to evaluate the severity of pulmonary fibrosis. (2) Mouse lung fibroblast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wei, Wang, Fangfang, Feng, Airan, Li, Xiaodan, Yu, Wencheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160725/ https://www.ncbi.nlm.nih.gov/pubmed/32337277 http://dx.doi.org/10.1155/2020/7840652

Ejemplares similares

Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
por: Pototskiy, Esther, et al.
Publicado: (2021)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

Author Correction: Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
por: Pototskiy, Esther, et al.
Publicado: (2021)

CD40/CD40 LIGAND INTERACTIONS IN IMMUNE RESPONSES AND PULMONARY IMMUNITY
por: KAWABE, TSUTOMU, et al.
Publicado: (2011)

RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
por: Chen, Yizhi, et al.
Publicado: (2023)

Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats
por: Song, Xiaoxia, et al.
Publicado: (2018)

CD40-CD40L Interaction in Immunity Against Protozoan Infections
por: Chamekh, Mustapha
Publicado: (2007)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
por: Cognasse, Fabrice, et al.
Publicado: (2022)

The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update
por: Senhaji, Nezha, et al.
Publicado: (2015)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation
por: Elmetwali, Taha, et al.
Publicado: (2020)

CD40/CD40L expression and its prognostic value in cervical cancer
por: Grazia, G.A., et al.
Publicado: (2023)

Expression of CD40 and CD40L in Gastric Cancer Tissue and Its Clinical Significance
por: Li, Rui, et al.
Publicado: (2009)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Multiple effects of CD40–CD40L axis in immunity against infection and cancer
por: Ara, Anjuman, et al.
Publicado: (2018)

Adipocytes in their (CD)40s
por: Bertola, Adeline, et al.
Publicado: (2023)

The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis
por: Mavroudi, Irene, et al.
Publicado: (2011)

Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016)

Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia
por: Zhang, Shungang, et al.
Publicado: (2020)

Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals
Publicado: (1995)

The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels
por: Liu, Zuo-Liang, et al.
Publicado: (2018)

CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease
por: Zhang, Shungang, et al.
Publicado: (2020)

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
por: Lacy, Michael, et al.
Publicado: (2021)

Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
por: Zhou, Aina, et al.
Publicado: (2023)

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
por: Teruel, María, et al.
Publicado: (2012)

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets
por: Chen, Tso-Hsiao, et al.
Publicado: (2015)

Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury
por: Tariket, Sofiane, et al.
Publicado: (2019)

CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
por: Daub, Steffen, et al.
Publicado: (2020)

Causal associations between CD40/CD40L and aortic diseases: A mendelian randomization study
por: Cui, Xiao, et al.
Publicado: (2022)

Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin
por: Yamauchi, Keita, et al.
Publicado: (2011)

Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis
por: Koyanagi, Yu, et al.
Publicado: (2023)

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40
Publicado: (1993)

The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus
por: Chen, Jian-Ming, et al.
Publicado: (2015)

Clinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease: A case-control study
por: Chen, Jun, et al.
Publicado: (2017)

The role of soluble CD40L in immunosuppression
por: Schlom, Jeffrey, et al.
Publicado: (2013)

Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats
por: Yu, Wencheng, et al.
Publicado: (2017)

A Critical Role for Cd40–Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response
por: Lefrançois, Leo, et al.
Publicado: (1999)

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
por: Naito, Masayasu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g35i20duem815t7n107cof9g8m